×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!
   

Early Economic Models pay off in Product Development

September 22, 2017

Creating an economic model normally occurs at Phase III of clinical research. However, if the product does not meet the target price it is too late to alter the trial design. This makes insights from early economic models key for cost effective drug development.

Convincing payers of drug cost-effectiveness is crucial for a profitable product. Predicting any potential pricing or data issues early on allows you to cost-effectively address problems and improve chances of reimbursement. 

Using real-life examples, see how PAREXEL helped clients build robust arguments for payer approval. 

Previous Presentation
The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions
The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

The Connected Journey™ of data-driven services powered by PAREXEL® Analytics

Next Flipbook
Five Ways to ensure your Early Engagement with Payers and Regulators Pays Off
Five Ways to ensure your Early Engagement with Payers and Regulators Pays Off

Read here about how PAREXEL Integrates clinical and commercial evidence planning.

×

Speak to one of our experts today

First Name
Last Name
Company Name
Title
Country
Tell us how we can help
We'll be in touch shortly!
Error - something went wrong!